Silver Spike Investment Corp. (SSIC)
USD 10.74
(1.27%)
USD 10.74
(1.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 88.57 Million USD | 1.85% |
| 2022 | 86.97 Million USD | 2.28% |
| 2021 | 85.03 Million USD | 30680.07% |
| 2020 | 276.25 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 90.35 Million USD | 2.0% |
| 2023 FY | 88.57 Million USD | 1.85% |
| 2023 Q4 | 88.57 Million USD | -0.68% |
| 2023 Q3 | 89.18 Million USD | -2.35% |
| 2023 Q2 | 91.33 Million USD | 1.5% |
| 2023 Q1 | 89.99 Million USD | 3.47% |
| 2022 Q3 | 85.89 Million USD | 0.69% |
| 2022 FY | 86.97 Million USD | 2.28% |
| 2022 Q4 | 86.97 Million USD | 1.25% |
| 2022 Q2 | 85.3 Million USD | 0.33% |
| 2022 Q1 | 85.03 Million USD | 0.0% |
| 2021 Q2 | 635.21 Thousand USD | 0.0% |
| 2021 FY | 85.03 Million USD | 30680.07% |
| 2020 FY | 276.25 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -33.608% |
| Safety Shot Inc | 12.7 Million USD | -596.947% |
| Bright Green Corporation | 17.4 Million USD | -408.97% |
| Embecta Corp. | 1.21 Billion USD | 92.706% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 90.206% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -54.266% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 92.253% |
| Dynavax Technologies Corporation | 997.09 Million USD | 91.117% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 56.959% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 87.838% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 94.374% |
| PainReform Ltd. | 9.93 Million USD | -792.007% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -223.898% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -223.898% |
| SCYNEXIS, Inc. | 128.41 Million USD | 31.022% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -282.998% |
| Journey Medical Corporation | 76.84 Million USD | -15.26% |
| Alpha Teknova, Inc. | 128.58 Million USD | 31.116% |
| Procaps Group, S.A. | 460.18 Million USD | 80.752% |
| Theratechnologies Inc. | 77.76 Million USD | -13.897% |
| Harrow Health, Inc. | 311.75 Million USD | 71.588% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -494.751% |
| Biofrontera Inc. | 27.93 Million USD | -217.114% |
| DURECT Corporation | 45.18 Million USD | -96.013% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 93.713% |
| Cronos Group Inc. | 1.13 Billion USD | 92.191% |
| OptiNose, Inc. | 107.72 Million USD | 17.779% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 81.197% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -58.316% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -284.327% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 80.745% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -643.203% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -8.316% |
| Radius Health, Inc. | 1.71 Billion USD | 94.838% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -66.225% |
| ProPhase Labs, Inc. | 91.92 Million USD | 3.645% |
| Phibro Animal Health Corporation | 982.18 Million USD | 90.982% |
| Procaps Group S.A. | 460.18 Million USD | 80.752% |
| Alvotech | 950.09 Million USD | 90.677% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -104.522% |
| Viatris Inc. | 47.68 Billion USD | 99.814% |
| Rockwell Medical, Inc. | 52.17 Million USD | -69.774% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 24.996% |
| SIGA Technologies, Inc. | 254.83 Million USD | 65.242% |
| Tilray Brands, Inc. | 4.33 Billion USD | 97.957% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 67.638% |
| Shineco, Inc. | 84.17 Million USD | -5.223% |
| PetIQ, Inc. | 868.22 Million USD | 89.798% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -949.704% |
| Incannex Healthcare Limited | 17.04 Million USD | -419.6% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 97.276% |
| Alimera Sciences, Inc. | 153.52 Million USD | 42.305% |
| Assertio Holdings, Inc. | 286.41 Million USD | 69.075% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -1388.243% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -162.093% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -183.508% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -568.624% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 66.079% |
| Hempacco Co., Inc. | 18.04 Million USD | -390.915% |
| Talphera, Inc. | 20.39 Million USD | -334.304% |
| Alvotech | 950.09 Million USD | 90.677% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 78.192% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 94.635% |
| Currenc Group, Inc. | 141.49 Million USD | 37.398% |
| Kamada Ltd. | 351.96 Million USD | 74.834% |
| Indivior PLC | 1.95 Billion USD | 95.461% |
| Evoke Pharma, Inc. | 7.06 Million USD | -1153.105% |
| Flora Growth Corp. | 23.62 Million USD | -274.91% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -568.624% |
| Evolus, Inc. | 188.99 Million USD | 53.134% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 93.079% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 94.145% |
| Akanda Corp. | 8.83 Million USD | -901.995% |